drugset / Trial / NCT01019551

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

NCT01019551 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Viral eradication in selected HIV-infected patients is possible with intensive antiretroviral therapy plus immunomodulation

Timeline

Start
2010-09
Primary completion
2012-07
Completion
2013-02

Outcome

Missed primary endpoint

paper No patient in either arm achieved the primary endpoint. PMID 26684819 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Interleukin-7 Protein / enzyme biologic 20 ug/kg —
Subject Maraviroc Other / unclassified 150 mg Oral
Subject Maraviroc Other / unclassified 300 mg Oral
Subject Maraviroc Other / unclassified 600 mg Oral
Subject Raltegravir Other / unclassified 400 mg Oral